BCL2L1 Antikörper (AA 19-127) (HRP)
Kurzübersicht für BCL2L1 Antikörper (AA 19-127) (HRP) (ABIN7145301)
Target
Alle BCL2L1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 19-127
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Bcl-2-like protein 10 protein (19-127AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- BCL2L1 (BCL2-Like 1 (BCL2L1))
-
Andere Bezeichnung
- BCL2L1
-
Hintergrund
-
Background: Promotes cell survival. Suppresses apoptosis induced by BAX but not BAK.
Aliases: Anti apoptotic protein NrH antibody, Anti-apoptotic protein NrH antibody, Apoptosis regulator Bcl B antibody, Apoptosis regulator Bcl-B antibody, B2L10_HUMAN antibody, BCL B antibody, Bcl-2-like protein 10 antibody, Bcl2 L 10 antibody, BCL2 like 10 (apoptosis facilitator) antibody, BCL2 like 10 protein antibody, Bcl2-L-10 antibody, Bcl2l10 antibody, BCLB antibody, Boo antibody, Diva antibody, MGC129810 antibody, MGC129811 antibody, Nrh antibody
-
UniProt
- Q9HD36
-
Pathways
- Apoptose, Negative Regulation of intrinsic apoptotic Signaling
Target
-